File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Chronic kidney disease: Global dimension and perspectives

TitleChronic kidney disease: Global dimension and perspectives
Authors
Issue Date2013
Citation
The Lancet, 2013, v. 382, n. 9888, p. 260-272 How to Cite?
AbstractSummary Chronic kidney disease is defined as a reduced glomerular filtration rate, increased urinary albumin excretion, or both, and is an increasing public health issue. Prevalence is estimated to be 8-16% worldwide. Complications include increased all-cause and cardiovascular mortality, kidney-disease progression, acute kidney injury, cognitive decline, anaemia, mineral and bone disorders, and fractures. Worldwide, diabetes mellitus is the most common cause of chronic kidney disease, but in some regions other causes, such as herbal and environmental toxins, are more common. The poorest populations are at the highest risk. Screening and intervention can prevent chronic kidney disease, and where management strategies have been implemented the incidence of end-stage kidney disease has been reduced. Awareness of the disorder, however, remains low in many communities and among many physicians. Strategies to reduce burden and costs related to chronic kidney disease need to be included in national programmes for non-communicable diseases. © 2013 Elsevier Ltd.
Persistent Identifierhttp://hdl.handle.net/10722/228475
ISSN
2023 Impact Factor: 98.4
2023 SCImago Journal Rankings: 12.113
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorJha, Vivekanand-
dc.contributor.authorGarcia-Garcia, Guillermo-
dc.contributor.authorIseki, Kunitoshi-
dc.contributor.authorLi, Zuo-
dc.contributor.authorNaicker, Saraladevi-
dc.contributor.authorPlattner, Brett-
dc.contributor.authorSaran, Rajiv-
dc.contributor.authorWang, Angela Yee Moon-
dc.contributor.authorYang, Chih Wei-
dc.date.accessioned2016-08-13T08:02:30Z-
dc.date.available2016-08-13T08:02:30Z-
dc.date.issued2013-
dc.identifier.citationThe Lancet, 2013, v. 382, n. 9888, p. 260-272-
dc.identifier.issn0140-6736-
dc.identifier.urihttp://hdl.handle.net/10722/228475-
dc.description.abstractSummary Chronic kidney disease is defined as a reduced glomerular filtration rate, increased urinary albumin excretion, or both, and is an increasing public health issue. Prevalence is estimated to be 8-16% worldwide. Complications include increased all-cause and cardiovascular mortality, kidney-disease progression, acute kidney injury, cognitive decline, anaemia, mineral and bone disorders, and fractures. Worldwide, diabetes mellitus is the most common cause of chronic kidney disease, but in some regions other causes, such as herbal and environmental toxins, are more common. The poorest populations are at the highest risk. Screening and intervention can prevent chronic kidney disease, and where management strategies have been implemented the incidence of end-stage kidney disease has been reduced. Awareness of the disorder, however, remains low in many communities and among many physicians. Strategies to reduce burden and costs related to chronic kidney disease need to be included in national programmes for non-communicable diseases. © 2013 Elsevier Ltd.-
dc.languageeng-
dc.relation.ispartofThe Lancet-
dc.titleChronic kidney disease: Global dimension and perspectives-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/S0140-6736(13)60687-X-
dc.identifier.pmid23727169-
dc.identifier.scopuseid_2-s2.0-84880511470-
dc.identifier.volume382-
dc.identifier.issue9888-
dc.identifier.spage260-
dc.identifier.epage272-
dc.identifier.eissn1474-547X-
dc.identifier.isiWOS:000322543700036-
dc.identifier.issnl0140-6736-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats